| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,934 |
11,483 |
$691K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,106 |
8,545 |
$372K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,229 |
3,180 |
$276K |
| 95250 |
|
2,482 |
2,427 |
$165K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
5,975 |
1,531 |
$131K |
| 76536 |
|
2,226 |
2,181 |
$125K |
| 95251 |
|
3,995 |
3,906 |
$65K |
| 99222 |
Initial hospital care, per day, moderate complexity |
857 |
797 |
$54K |
| 83037 |
|
6,222 |
6,135 |
$37K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
680 |
635 |
$31K |
| 82947 |
|
11,608 |
10,623 |
$22K |
| 99215 |
Prolong outpt/office vis |
254 |
245 |
$21K |
| 99406 |
|
1,572 |
1,448 |
$11K |
| 99205 |
Prolong outpt/office vis |
70 |
69 |
$8K |
| 10005 |
|
93 |
93 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
513 |
503 |
$3K |
| 90756 |
|
137 |
126 |
$2K |
| 82948 |
|
536 |
511 |
$847.02 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
44 |
40 |
$616.31 |
| 90674 |
|
27 |
26 |
$457.78 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
228 |
221 |
$245.97 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
24 |
$176.81 |
| G0008 |
Administration of influenza virus vaccine |
70 |
69 |
$149.82 |
| 82570 |
|
23 |
23 |
$43.55 |
| 84443 |
Thyroid stimulating hormone (TSH) |
43 |
35 |
$24.81 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
13 |
$16.20 |
| 84439 |
|
43 |
35 |
$8.44 |
| 3051F |
|
1,274 |
1,260 |
$1.14 |
| 3052F |
|
734 |
727 |
$0.44 |
| 2022F |
|
390 |
388 |
$0.42 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
6,401 |
6,091 |
$0.01 |
| 3046F |
|
1,598 |
1,577 |
$0.01 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
5,521 |
5,182 |
$0.01 |
| 1036F |
|
7,661 |
7,206 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,551 |
2,426 |
$0.00 |
| 3044F |
|
1,823 |
1,810 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
365 |
358 |
$0.00 |
| 1123F |
|
158 |
153 |
$0.00 |
| G8724 |
Pt category, pn category and histologic grade were not documented in the pathology report, reason not given |
182 |
179 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
206 |
199 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
682 |
642 |
$0.00 |
| 1124F |
|
557 |
532 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
9,664 |
8,892 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
496 |
480 |
$0.00 |
| 4004F |
|
1,519 |
1,419 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
187 |
180 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
2,386 |
2,333 |
$0.00 |
| 3045F |
|
458 |
439 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
183 |
180 |
$0.00 |